Laparoscopic completion radical cholecystectomy for T2 gallbladder cancer
- PMID: 20499105
- DOI: 10.1007/s00464-010-1102-2
Laparoscopic completion radical cholecystectomy for T2 gallbladder cancer
Abstract
Background: The role of minimally invasive surgery in the surgical management of gallbladder cancer is a matter of controversy. Because of the authors' growing experience with laparoscopic liver and pancreatic surgery, they have begun offering patients laparoscopic completion partial hepatectomies of the gallbladder bed with laparoscopic hepatoduodenal lymphadenectomy.
Methods: The video shows the steps needed to perform laparoscopic resection of the residual gallbladder bed, the hepatoduodenal lymph node nodes, and the residual cystic duct stump in a setting with a positive cystic stump margin. The skin and fascia around the previous extraction site are resected, and this site is used for specimen retrieval during the second operation.
Results: To date, three patients have undergone laparoscopic radical cholecystectomy with hepatoduodenal lymph node dissection for gallbladder cancer. The average number of lymph nodes retrieved was 3 (range, 1-6), and the average estimated blood loss was 117 ml (range, 50-200 ml). The average operative time was 227 min (range, 120-360 min), and the average hospital length of stay was 4 days (range, 3-5 days). No morbidity or mortality was observed during 90 days of follow-up for each patient.
Conclusion: Although controversy exists as to the best surgical approach for gallbladder cancer diagnosed after routine laparoscopic cholecystectomy, the minimally invasive approach seems feasible and safe, even after previous hepatobiliary surgery. If the previous extraction site cannot be ascertained, all port sites can be excised locally. Larger studies are needed to determine whether the minimally invasive approach to postoperatively diagnosed early-stage gallbladder cancer has any drawbacks.
Similar articles
-
Laparoscopic bile duct resection with lymph node dissection for gallbladder cancer diagnosed after laparoscopic cholecystectomy.Surg Oncol. 2020 Dec;35:475. doi: 10.1016/j.suronc.2020.10.006. Epub 2020 Oct 16. Surg Oncol. 2020. PMID: 33096445
-
Lateral approach toward hepatoduodenal ligament during laparoscopic radical cholecystectomy for Gallbladder cancer.Surg Oncol. 2020 Sep;34:146. doi: 10.1016/j.suronc.2020.04.009. Epub 2020 Apr 17. Surg Oncol. 2020. PMID: 32891320
-
Laparoscopic radical cholecystectomy and Roux-en-Y choledochojejunostomy for gallbladder cancer.Surg Endosc. 2010 Jul;24(7):1766-8. doi: 10.1007/s00464-009-0840-5. Epub 2010 Jan 7. Surg Endosc. 2010. PMID: 20054570
-
Port site recurrence of unexpected gallbladder carcinoma after a laparoscopic cholecystectomy: report of a case.Surg Today. 1999;29(1):71-5. doi: 10.1007/BF02482974. Surg Today. 1999. PMID: 9934836 Review.
-
Gallbladder carcinoma: Prognostic factors and therapeutic options.World J Gastroenterol. 2015 Nov 21;21(43):12211-7. doi: 10.3748/wjg.v21.i43.12211. World J Gastroenterol. 2015. PMID: 26604631 Free PMC article. Review.
Cited by
-
Current Role of Minimally Invasive Radical Cholecystectomy for Gallbladder Cancer.Gastroenterol Res Pract. 2016;2016:7684915. doi: 10.1155/2016/7684915. Epub 2016 Nov 3. Gastroenterol Res Pract. 2016. PMID: 27885325 Free PMC article. Review.
-
Treatment of Resectable Gallbladder Cancer.Cancers (Basel). 2022 Mar 10;14(6):1413. doi: 10.3390/cancers14061413. Cancers (Basel). 2022. PMID: 35326566 Free PMC article. Review.
-
Comparison of the Oncological Outcomes of Open versus Laparoscopic Surgery for T2 Gallbladder Cancer: A Propensity-Score-Matched Analysis.J Clin Med. 2022 May 8;11(9):2644. doi: 10.3390/jcm11092644. J Clin Med. 2022. PMID: 35566770 Free PMC article.
-
Oncologic safety of laparoscopic radical cholecystectomy in pT2 gallbladder cancer: A propensity score matching analysis compared to open approach.Medicine (Baltimore). 2020 May;99(20):e20039. doi: 10.1097/MD.0000000000020039. Medicine (Baltimore). 2020. PMID: 32443308 Free PMC article. Review.
-
Laparoscopic approach to suspected T1 and T2 gallbladder carcinoma.World J Gastroenterol. 2017 Apr 14;23(14):2556-2565. doi: 10.3748/wjg.v23.i14.2556. World J Gastroenterol. 2017. PMID: 28465640 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical